AbbVie vs Toyota: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Toyota was founded in 1937 by Kiichiro Toyoda, Sakichi Toyoda and is led by Kenta Kon.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Toyota
Kiichiro Toyoda
Kiichiro Toyoda (1894-1952) founded the Toyota Motor Corporation in 1937, spinning it out of his father's successful textile machinery business.
Sakichi Toyoda
Sakichi Toyoda was not the founder of Toyota Motor Corporation but his inventions and philosophy created the foundation on which it was built. His loom patents generated the capital Kiichiro needed to experiment with automobiles.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Toyota
- Akio Toyoda2009–2023
President and Chief Executive Officer (now Chairman)
Akio Toyoda took leadership during one of Toyota's hardest modern periods, including the global financial crisis and the unintended acceleration recall crisis.
Source - Koji Sato2023–2026
President and Chief Executive Officer (now Vice Chairman)
Koji Sato inherited a profitable but scrutinized Toyota.
Source - Kenta Kon2026–present
President and Chief Executive Officer
As CFO, he managed the immense capital allocation required for Toyota's massive $35 billion commitment to fully electrify its vehicle lineup by 2030.
Source
Timeline: AbbVie and Toyota side by side
1937Toyota
Toyota Motor Corporation incorporated
Toyota Motor Corporation was incorporated after Kiichiro Toyoda expanded the Toyoda family business from automatic looms into automobile manufacturing.
1955Toyota
Toyopet Crown launched
The Toyopet Crown gave Toyota a postwar passenger-car platform and later became its first passenger car exported to the United States.
1966Toyota
Corolla launched
Toyota launched the Corolla, a compact car that became central to its mass-market export strategy.
1989Toyota
Lexus launches
Toyota launched Lexus with the LS 400, moving into premium vehicles with a quality-led strategy.
1997Toyota
Prius launches in Japan
Toyota launched the Prius, turning hybrid technology into a mass-produced passenger vehicle.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2016Toyota
Acquired Daihatsu Motor Co., Ltd.
Toyota Motor acquired Daihatsu Motor Co., Ltd..
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2021Toyota
Acquired Lyft Level 5
Toyota Motor acquired Lyft Level 5 for $550 million.
2021Toyota
Acquired CARMERA
Toyota Motor acquired CARMERA.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
2026Toyota
Kenta Kon becomes president and CEO
Kenta Kon became president and CEO on April 1, 2026, while Koji Sato moved to vice chairman and chief industry officer.
2026Toyota
FY2026 sales revenues reach ~$340B (JPY 50.685T)
Toyota reported FY2026 sales revenues of ~$340 billion (JPY 50,684.952 billion) and net income attributable to Toyota Motor Corporation of ~$25.8 billion (JPY 3,848.098 billion).
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Toyota
- Lyft Level 52021$550M
- CARMERA2021Undisclosed
- Renovo Motors2021Undisclosed
- Daihatsu Motor Co., Ltd.2016Undisclosed
- Toyota Auto Body2012Undisclosed
Questions about AbbVie vs Toyota
Who is the CEO of AbbVie Inc. and Toyota Motor Corporation?
AbbVie Inc. is led by Robert A. Michael and Toyota Motor Corporation is led by Kenta Kon. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Toyota Motor Corporation?
Toyota Motor Corporation was founded in 1937 — 76 years before AbbVie Inc., which was founded in 2013. Toyota Motor Corporation's longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Toyota Motor Corporation?
AbbVie Inc. employs approximately 57,000 people, while Toyota Motor Corporation employs approximately 375,235. Toyota Motor Corporation has the larger workforce at 375,235 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Toyota Motor Corporation headquartered?
AbbVie Inc. is headquartered in United States and Toyota Motor Corporation is headquartered in Japan. Their different home markets mean they may face different regulatory frameworks, tax regimes, and currency exposure.
Who founded AbbVie Inc. and Toyota Motor Corporation?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Toyota Motor Corporation was founded by Kiichiro Toyoda, Sakichi Toyoda.
Which company has a longer operating history — AbbVie Inc. or Toyota Motor Corporation?
Toyota Motor Corporation has been operating for approximately 89 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Toyota overview